Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	183.86	493.91	1,016	2,556	1,190	669.11
Short-Term Investments	3,162	738.79	-	70	-	-
Trading Asset Securities	404.92	64.12	122.59	1,953	700	200
Cash & Short-Term Investments	3,750	1,297	1,138	4,578	1,890	869.11
Cash Growth	572.47%	13.93%	-75.14%	142.22%	117.48%	134.57%
Accounts Receivable	652.72	766.95	1,254	2,736	740.42	185.03
Other Receivables	17.81	80.52	70.28	17.52	11.97	5.46
Receivables	670.53	847.47	1,324	2,754	752.39	190.49
Inventory	101.35	82.3	128.77	258.44	284.59	117.73
Other Current Assets	224.06	171.08	158.83	91.09	72.98	40.77
Total Current Assets	4,746	2,398	2,750	7,682	3,000	1,218
Property, Plant & Equipment	676.65	721.68	543.6	521.59	243.47	123.26
Long-Term Investments	254.22	257.61	156.36	83.49	60.62	46.4
Other Intangible Assets	16.61	17.3	17.7	21.24	16.59	16.93
Long-Term Deferred Tax Assets	216.26	216.9	210.18	173.95	16.63	7.6
Long-Term Deferred Charges	2.32	3.11	14.87	17.21	1.45	1.74
Other Long-Term Assets	188.68	2,979	3,694	695.33	78.24	12.61
Total Assets	6,101	6,593	7,387	9,195	3,417	1,427
Accounts Payable	144.76	278.11	681.58	1,294	174.31	30.94
Accrued Expenses	52.38	87.97	154.94	364.68	83.18	29.78
Short-Term Debt	3	3	23.61	164.67	30	141.5
Current Portion of Leases	4.3	4.3	7.29	18.17	3.62	-
Current Income Taxes Payable	5.77	6.44	6.27	144.02	131.8	24.58
Current Unearned Revenue	35.28	37.96	53.17	309.58	71.18	27.74
Other Current Liabilities	52.01	78.07	92.5	69.96	51.9	54.87
Total Current Liabilities	297.5	495.86	1,019	2,365	545.98	309.42
Long-Term Leases	3.45	5.82	18.25	20.75	10.74	-
Long-Term Unearned Revenue	20.87	20.87	14.26	5.96	5.96	0.02
Long-Term Deferred Tax Liabilities	51.67	50.42	39.59	31.07	4.33	2.32
Other Long-Term Liabilities	0.22	1.44	3.03	-	-	-
Total Liabilities	373.7	574.4	1,094	2,423	567.02	311.77
Common Stock	232.5	232.52	232.52	156.19	104.88	69.01
Additional Paid-In Capital	818.1	818.1	820.18	887.89	904.5	400.24
Retained Earnings	4,758	5,014	4,973	5,472	1,812	681.94
Treasury Stock	-247.96	-237.95	-	-16.02	-32.77	-49.39
Total Common Equity	5,561	5,826	6,026	6,500	2,789	1,102
Minority Interest	166.32	192.29	266.21	271.92	61.25	13.09
Shareholders' Equity	5,727	6,019	6,292	6,772	2,850	1,115
Total Liabilities & Equity	6,101	6,593	7,387	9,195	3,417	1,427
Total Debt	10.75	13.11	49.16	203.59	44.36	141.5
Net Cash (Debt)	3,740	1,284	1,089	4,375	1,846	727.61
Net Cash Growth	605.79%	17.87%	-75.10%	137.02%	153.67%	96.38%
Net Cash Per Share	17.24	5.68	4.80	19.03	8.72	3.49
Filing Date Shares Outstanding	219.47	220.05	232.52	232.73	232.84	214.48
Total Common Shares Outstanding	219.47	220.05	232.52	232.73	232.84	214.48
Working Capital	4,449	1,902	1,731	5,317	2,454	908.68
Book Value Per Share	25.34	26.48	25.92	27.93	11.98	5.14
Tangible Book Value	5,545	5,809	6,008	6,479	2,772	1,085
Tangible Book Value Per Share	25.26	26.40	25.84	27.84	11.91	5.06
Buildings	-	440.3	116.98	116.66	78	51.08
Machinery	-	380.8	402.91	374.05	158.18	113.44
Construction In Progress	-	120.79	185.19	121.52	73.58	19.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.